title: Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma.
authors.affiliation: Medical College of Wisconsin, Milwaukee, WI phari@mcw.edu.
authors.forename: Parameswaran
authors.initials: P
authors.lastname: Hari
authors.affiliation: Medical College of Wisconsin, Milwaukee, WI phari@mcw.edu.
authors.forename: Renju V
authors.initials: RV
authors.lastname: Raj
authors.affiliation: Medical College of Wisconsin, Milwaukee, WI phari@mcw.edu.
authors.forename: Horatiu
authors.initials: H
authors.lastname: Olteanu
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000037:antagonists & inhibitors*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy*; D008562:Membrane Glycoproteins / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D012008:Recurrence
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D008562:Membrane Glycoproteins; C556306:daratumumab; C498154:CD38 protein, human; D051997:ADP-ribosyl Cyclase 1